STAT+: Embryo editing advances reignite ethical debates

Дата публикации: 26-06-2026 13:40:44

Cassidy targets 340B, Eli Lilly's mysterious retatrutide patient, and more biotech news from The Readout

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Supreme Court rules in weedkiller cancer case	0	5	26-06-2026
2	The mysterious case of Eli Lilly’s obesity drug	0	5	25-06-2026
3	STAT+: Next-gen CRISPR tools improve editing accuracy in embryos, but also stoke ethical concerns	0	7	25-06-2026
4	STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better	0	7	25-06-2026
5	STAT+: Cassidy proposes bill to rein in 340B drug discount program	0	5	25-06-2026
6	STAT+: Pharmalittle: We’re reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more	0	3	26-06-2026
7	STAT+: Democrats press White House on who got special access to Eli Lilly’s new obesity drug	0	7	25-06-2026
8	STAT+: European antitrust regulators probe Sanofi for allegedly disparaging a rival flu vaccine	0	7	26-06-2026
9	BIO 2026: AI, federal policy impacts, and general vibes	0	5	26-06-2026
10	Senate Days Are Numbered for Top Republican Charged With Ed. Dept. Oversight	0	5	18-05-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: www.statnews.com.